本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lipella Pharmaceuticals Inc

2.56
+0.09003.64%
成交量:4,309.00
成交额:1.09万
市值:652.50万
市盈率:-0.53
高:2.56
开:2.56
低:2.50
收:2.47
数据加载中...
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/01

重要事件披露

Form 8-K - Current report
2024/10/18

重要事件披露

Form 8-K - Current report
2024/10/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/11

重要事件披露

Form 8-K - Current report
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/20

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/01

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/12

重要事件披露

Form 8-K - Current report
2024/03/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/15

重要事件披露

Form 8-K - Current report
2024/03/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans